Ask Warren

Ilyang Pharmaceutical

007570 · KOSPI · ₩007570 · 일양약품

₩6,960▲ ₩50 (0.72%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩65B₩65B₩79B₩69B₩63B₩62B₩8.5B₩99B
Cost of sales₩41B₩41B₩45B₩41B₩36B₩33B₩38B₩45B
Gross profit₩24B₩24B₩34B₩28B₩27B₩29B−₩30B₩54B
Operating income−₩6.8B−₩7.4B₩566M−₩158M₩1.2B₩3.4B−₩43M₩5.5B
Net income−₩19B₩17B−₩1.3B₩7.8B−₩3.2B₩3.8B₩6.7B₩2B
Net income to shareholders−₩2.3B₩17B−₩5.6B₩8.4B₩577M₩3.5B₩3.7B₩3.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩452B₩466B₩457B₩453B₩445B₩437B₩431B₩534B
Current assets₩136B₩153B₩148B₩147B₩140B₩131B₩125B₩206B
Cash and equivalents₩13B₩35B₩24B₩9.8B₩5.6B₩4.9B₩4.3B₩15B
Total liabilities₩195B₩208B₩216B₩205B₩205B₩195B₩190B₩262B
Current liabilities₩155B₩164B₩171B₩160B₩160B₩154B₩157B₩230B
Borrowings₩103B₩112B₩126B₩119B₩122B₩114B₩93B₩122B
Total equity₩257B₩258B₩241B₩248B₩239B₩242B₩242B₩271B
Shareholders' equity₩253B₩254B₩238B₩244B₩236B₩238B₩238B₩232B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩6.8B₩27B₩7.9B₩6.8B₩2.3B−₩5B₩20B−₩24B
Capital spending₩2.4B₩232M₩744M₩2.8B₩1.9B₩260M₩14B₩14B
Free cash flow−₩9.1B₩26B₩7.2B₩4B₩355M−₩5.2B₩5.8B−₩38B
Dividends paid₩2.9B₩403M₩0₩0₩2.8B₩101M−₩900M₩4.1M

Consolidated where available. Amounts in won.

Also known as: Ilyang Pharmaceutical / 일양약품 / 007570 / KRX:007570

Source: KRX statistical information